Constellium GAAP EPS of $0.84 beats by $0.14, revenue of $2.6B beats by $130M (CSTM:NYSE)

Constellium reported Q3 GAAP EPS of $0.84, exceeding estimates by $0.14, with revenue of $2.6B, up 18.2% year-over-year and $130M above expectations. Shipments decreased 1% compared to the same period last year. The company raised its outlook based on current trends.

Original reporting
Published Oct 28, 2026, 10:04 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 10:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CSTM
Bullish
high confidence
Mentioned
$CSTM
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$CSTMBullishHigh
01

Why it matters

The earnings beat is likely to drive short‑term buying pressure, especially in pre‑market trading.

02

Market read

First‑report earnings beat provides fresh actionable data for traders.

03

What to watch

Guidance outlook and cash flow details were not disclosed, limiting forward visibility.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Constellium SE reported its Q3 2026 earnings, beating both EPS and revenue expectations.

Company-level read

Ticker impact

$CSTMBullishHigh confidence
Context

Q3 GAAP EPS $0.84 beats expectations by $0.14 and revenue $2.6B beats by $130M.

Expected impact

likely upside as market prices in the earnings beat

Evidence & confidence

Both EPS and revenue exceeded consensus, indicating better-than-expected performance.

Market effects

supports the aluminum and specialty metals sector with a positive earnings surprise.

boosts US industrial stocks in early trading.

may influence global metal pricing and competitor outlooks.

Counterpoint

The beat could be a one‑off; underlying demand may still be weak.

Key entities

  • Constellium SE

    Aluminum products manufacturer listed on NYSE under CSTM.

Related articles

$EROMed

Five Metals Producers Trade Higher as Gold, Silver and Copper Futures Pull Back

Five metals producers (Ero Copper, Nexa Resources, Constellium, Algoma Steel, New Found Gold) traded higher despite pullbacks in gold, silver, and copper futures. Ero Copper reported record Q3 results with copper and gold production increases. Nexa Resources saw a 62% YoY rise in adjusted EBITDA. Constellium raised its 2026 guidance. Algoma Steel transitioned to electric arc furnace steelmaking. New Found Gold updated its Queensway project assessment.

$CSTMHigh

JPMorgan upgrades Constellium stock rating on earnings beat

JPMorgan upgraded Constellium (CSTM) to Overweight, raising its price target to $35.00. The move follows CSTM's Q3 earnings beat, with adjusted EBITDA of $280M, 12% above estimates. The company also raised its fiscal 2026 EBITDA guidance. CSTM's stock has declined 16% in the past three months, despite strong Q3 results and a positive outlook on demand.

$CSTMMed

Constellium reports strong 2026 results

Constellium reported Q3 2026 revenue of $2.6B, up 22% YoY, and net income of $119M, up $31M. Shipments fell 1% to 368,000 tonnes. CEO Ingrid Joerg attributed growth to operational focus and market dynamics. Adjusted EBITDA rose to $276M, up $41M. Nine-month revenue reached $7.8B, up 26%, with net income at $463M, up $301M.

$CSTMMed

Constellium SE Q3 2026 Earnings Call Summary

Constellium SE reported record Q3 2026 earnings, driven by strong aerospace and North American automotive markets. The company raised 2026 EBITDA guidance to $1.03B-$1.06B. Management expects significant aerospace growth in 2027, supported by OEM build rates and tight market capacity. Strategic investments in recycling and new facilities are expected to provide cost advantages and meet growing demand.

$CSTMHighAI 8/10

Constellium (CSTM) Q3 2026 Earnings Call Transcript

Constellium (CSTM) reported Q3 2026 earnings, with revenue up 22% YoY to $2.6B and adjusted EBITDA up 17% to $276M. The company raised its full-year outlook, citing strong performance and favorable market dynamics. It also discussed manageable impacts from the Middle East conflict. Free cash flow was $128M, and $30M was returned to shareholders via share repurchases.